Ekalia Overview
- Status
-
Private
- Latest Deal Type
-
Joint Venture
- Financing Rounds
-
1
Ekalia General Information
Description
Producer of medical radioisotopes intended to support targeted cancer therapies. The company utilizes cyclotron technology to produce alpha-emitting radioisotopes, deploys a decentralized network of production sites for timely isotope delivery, combines particle accelerator and nuclear expertise to build resilient supply chains, and enables nuclear medicine providers to access a reliable and scalable supply of Astatine-211 for precision oncology treatments.
Contact Information
Corporate Office
- Courbevoie
- France
Corporate Office
- Courbevoie
- France
Ekalia Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Ekalia Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Ekalia FAQs
-
Where is Ekalia headquartered?
Ekalia is headquartered in Courbevoie, France.
-
What industry is Ekalia in?
Ekalia’s primary industry is Biotechnology.
-
Is Ekalia a private or public company?
Ekalia is a Private company.
-
What is Ekalia’s current revenue?
The current revenue for Ekalia is .
-
Who are Ekalia’s investors?
Framatome and Ion Beam Applications have invested in Ekalia.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process